Works in Drug Design, Development & Therapy, 2018, Vol 12


Results: 380
    1
    2
    3
    4
    5

    SREBP-2, a new target of metformin?

    Published in:
    Drug Design, Development & Therapy, 2018, v. 12, p. 4163, doi. 10.2147/DDDT.S190094
    By:
    • Zhang, Fengxia;
    • Sun, Wenxiu;
    • Chen, Jianbo;
    • Jiang, Lusheng;
    • Yang, Ping;
    • Huang, Yufang;
    • Gong, Aihua;
    • Liu, Shudong;
    • Ma, Shizhan
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study.

    Published in:
    Drug Design, Development & Therapy, 2018, v. 12, p. 4217, doi. 10.2147/DDDT.S172046
    By:
    • Han, Seung Hwan;
    • Oh, Gyu Chul;
    • Kwon, Hyuck Moon;
    • Park, Chang Gyu;
    • Kim, In Jai;
    • Hwang, Gyo-Seung;
    • Yoo, Byung Su;
    • Park, Seong Hoon;
    • Lee, Kwang Je;
    • Kim, Hyo-soo
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50